Nanobiotix annual r&d spending
2018
2019
2020
2021
2022
2023
2024
2025
Nanobiotix R&D Spending Growth & History (NANO)
Nanobiotix's r&d spending was €23.1M for fiscal 2025.
View full Nanobiotix company overviewNanobiotix annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €23.1M | −€17.4M | −42.98% |
| 2024 | 2024-12-31 | €40.5M | €2.1M | +5.59% |
| 2023 | 2023-12-31 | €38.4M | €5.8M | +17.65% |
| 2022 | 2022-12-31 | €32.6M | €2.3M | +7.43% |
| 2021 | 2021-12-31 | €30.4M | €6.0M | +24.86% |
| 2020 | 2020-12-31 | €24.3M | −€6.1M | −20.00% |
| 2019 | 2019-12-31 | €30.4M | €9.5M | +45.56% |
| 2018 | 2018-12-31 | €20.9M | — | — |
Nanobiotix r&d spending trends
Over the last five fiscal years, Nanobiotix's r&d spending decreased from €24.3M to €23.1M, a change of −€1.2M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nanobiotix source filings ↗